Filed: 5/14/2026ACC: 0001104659-26-060911
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $230.71M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$230.71M
Total AUM (reported)
9.40M
Total Shares
Allocation by class
COM$230.71M100.0%
Portfolio Concentration
Top 3$230.71M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.40M
Sole
Full voting authority
9.40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Mineralys Therapeutics, Inc.
SOLEShares7.90M
TypeSH
Market value$214.11M
92.81%
Sole
7.90M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares1.49M
TypeSH
Market value$16.60M
7.19%
Sole
1.49M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 7.90M | SH | $214.11M 92.81% | 7.90M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 1.49M | SH | $16.60M 7.19% | 1.49M | 0.00 | 0.00 |